Office of Policy & Legislative Affairs
An Online Resource for Skilled Immigrants
Licensing Resources for Veterans
Construction Codes
Community and Health Systems
Corporations, Securities & Commercial Licensing Bureau.
Michigan Office of Administrative Hearings and Rules
Professional Licensing
Search is currently unavailable. Please try again later.
The web Browser you are currently using is unsupported, and some features of this site may not work as intended. Please update to a modern browser such as Chrome, Firefox or Edge to experience all features Michigan.gov has to offer.
Board of Pharmacy Administrative Rule 338.3162b states all pharmacies, dispensing practitioners, and veterinarians who dispense schedules 2-5 controlled substances are required to electronically report this prescription data to MAPS on a daily basis. The data required by Rule 338.3162b shall be forwarded to the department by the end of the next business day and shall include data for all controlled substances dispensed since the previous transmission or report.
Controlled substance dispensations should be reported to MAPS via the PMP Clearinghouse. To register, please go to https://pmpclearinghouse.net. Please review the Data Submission Dispenser Guide below for additional information.
Reporting exemptions include controlled substances administered to patients, samples of controlled substances provided to a patient, and controlled substances that are dispensed by a physician at a medical institution for a maximum of 48 hours.
A waiver may be requested by dispensers, dispensing practitioners, or veterinarians who do not have the appropriate software to record and report prescription data, which will enable those to submit their prescription data in paper form. Upon approval of the waiver application, a MAPS Claim Form is required to be completed for each controlled substance dispensed and then emailed, faxed, or mailed to MAPS for submission into the database.
Michigan Data Submission Dispenser Guide
The State of Michigan is covering the full cost of integration of MAPS into the clinical workflow of health systems, physician groups and pharmacies through at least September 30. 2025. Learn how to start the integration process.
If your question(s) pertain to the new opioid legislation, we encourage you to review the recently-released FAQs. Additional questions or concerns can be addressed by contacting MAPS.
